We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
Cap. Flow
+$831M
Cap. Flow %
11.61%
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$146M
2
GILD icon
Gilead Sciences
GILD
+$116M
3
AMZN icon
Amazon
AMZN
+$86.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$84.7M
5
ADI icon
Analog Devices
ADI
+$80M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$73.2M
2
PANW icon
Palo Alto Networks
PANW
+$59.8M
3
ALKS icon
Alkermes
ALKS
+$55.3M
4
ACN icon
Accenture
ACN
+$53.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.05%
2 Technology 29.2%
3 Financials 8.76%
4 Industrials 7.7%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTC
501
DELISTED
Northern Star Investment Corp. III
NSTC
$1.48M 0.02%
150,000
– –
BLUA
502
DELISTED
BlueRiver Acquisition Corp.
BLUA
$1.47M 0.02%
148,441
– –
NSTD
503
DELISTED
Northern Star Investment Corp. IV
NSTD
$1.47M 0.02%
150,000
– –
ELDN icon
504
Eledon Pharmaceuticals
ELDN
$267M
$1.43M 0.02%
516,675
– –
PIPP
505
DELISTED
Pine Island Acquisition Corp.
PIPP
$1.4M 0.02%
140,000
+100,000
+250% +$993K
TBSA
506
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
$1.39M 0.02%
+140,750
New +$1.39M
THRX
507
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.37M 0.02%
236,390
+24,706
+12% +$175K
NRAC
508
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$1.36M 0.02%
+136,698
New +$1.35M
EVGR
509
DELISTED
Evergreen Corporation Class A Ordinary Share
EVGR
$1.34M 0.02%
+132,960
New +$1.33M
ANTX icon
510
AN2 Therapeutics
ANTX
$219M
$1.32M 0.02%
76,145
-31,155
-29% -$363K
DOX icon
511
Amdocs
DOX
$6.28B
$1.32M 0.02%
+16,643
New +$1.41M
SNAP icon
512
Snap
SNAP
$8.83B
$1.31M 0.02%
+133,729
New +$1.56M
CALX icon
513
Calix
CALX
$2.36B
$1.29M 0.02%
21,070
-1,004
-5% -$53.7K
BRD
514
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
$1.25M 0.02%
125,000
– –
OBIO icon
515
Orchestra BioMed
OBIO
$249M
$1.25M 0.02%
126,061
-277,638
-69% -$2.75M
WTMA
516
DELISTED
Welsbach Technology Metals Acquisition Corp. Common Stock
WTMA
$1.25M 0.02%
125,000
– –
ZBRA icon
517
Zebra Technologies
ZBRA
$17.2B
$1.24M 0.02%
4,747
+3,015
+174% +$933K
COLI
518
DELISTED
Colicity Inc. Class A Common Stock
COLI
$1.23M 0.02%
125,000
– –
SVFB
519
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$1.23M 0.02%
+123,698
New +$1.22M
HLIT icon
520
Harmonic Inc
HLIT
$1.27B
$1.22M 0.02%
93,359
-71,643
-43% -$774K
TBPH icon
521
Theravance Biopharma
TBPH
$877M
$1.22M 0.02%
119,854
-2,123,619
-95% -$19.9M
ODP
522
DELISTED
ODP
ODP
$1.2M 0.02%
+34,239
New +$1.22M
MDGL icon
523
Madrigal Pharmaceuticals
MDGL
$11.8B
$1.18M 0.02%
18,123
-64,053
-78% -$4.45M
SLN
524
Silence Therapeutics
SLN
$554M
$1.16M 0.02%
+115,120
New +$1.21M
HAACU
525
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$1.12M 0.02%
111,990
– –
19 20
21
22 23

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.

  • Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
  • Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
  • Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
  • Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
  • Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
  • Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
  • Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.